Fig. 3.
Tornado diagram showing the impact of varying transition probabilities and treatment costs on incremental healthcare costs across breast cancer molecular subtypes. D&T: Diagnosis and treatment; L: Lines of systemic therapy (2L: second therapy line; 3L: third therapy line; 4L: fourth therapy line); LRR: Locoregional recurrence; LUM A: Luminal A; LUMA B: Luminal B; TNBC: Triple-negative breast cancer; TP: Transition probabilities; UDC: Undiagnosed cancer. *The vertical dashed line represents no change from the base case (Δ healthcare costs = 0). Dark grey bars indicate the change when the parameter is set to its lower bound, and light grey bars indicate the change when set to its upper bound